Accuray’s Bold Move: A Game Changer in Oncology?by Mark Eisenberg 13.02.2024Accuray's strategic move into emerging markets, including China and India, is expected to bolster its growth outlook and attract investor ...
Ottawa County’s Life-Saving PulsePoint Appby Lilu Anderson 13.02.2024HeartSafe Holland and the Ottawa County Central Dispatch Authority have partnered to bring the PulsePoint app to Ottawa County, offering ...
Dispensa Group Delists from UK Stock Marketby Mark Eisenberg 13.02.2024Dispensa Group plans to delist its shares from the Financial Conduct Authority's official list and the London Stock Exchange. The ...
Bill Ackman’s $10B Fund Launch: Defying Market Oddsby Terry Bingman 13.02.2024Renowned investor Bill Ackman is launching Pershing Square USA Ltd, the largest U.S. closed-end fund, aiming to raise over $10 ...
Zillow’s Resilient Fourth-Quarter Earningsby Mark Eisenberg 13.02.2024Zillow's Q4 earnings show resilience despite housing market challenges. Analysts predict a moderate increase in revenue thanks to decreasing mortgage ...
GreenPower Motor Co. Inc. Surges 40%by Mark Eisenberg 13.02.2024GreenPower Motor Co. reports a 40% surge in revenues, reaching $34.2 million. Expansion of dealer network and innovative electric buses ...
Beamr Imaging’s $12M Raise Boosts Video Techby John Darbie 13.02.2024Beamr Imaging, a video optimization technology company, plans to raise $12 million through a public offering. The funds will support ...
BlackBerry’s Profit Push Amid Restructuringby Lilu Anderson 13.02.2024BlackBerry aims to enhance profitability and cash flow by targeting $100 million in net profit improvements. The company has already ...
Shopify’s Reset Sparks Stock Surge: What’s Next?by Mark Eisenberg 13.02.2024Shopify's Q4 earnings report is expected to showcase positive progress, with adjusted earnings per share of 30 cents, projected revenue ...
CSL’s Profit Soars 17%, Plasma Business Boomby Terry Bingman 13.02.2024Australia-based pharmaceuticals company CSL has reported a 17% increase in half-year net profit, driven by strong performance in its blood-plasma ...